Search research articles
Contact Us
Filters
Showing results (41-50 of 73) with videos related to
Page
of 8
Sort By:
JAMA Cardiology
|
May 1, 2018
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial
Brian A Bergmark, Jacob A Udell, David A Morrow, et al.
Hepatology (Baltimore, Md.)
|
May 26, 2007
Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus
Leland J Yee, Yong-Ming Tang, David E Kleiner, et al.
Journal of the American College of Cardiology
|
February 7, 2024
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
Daniel J McClintick, Michelle L O'Donoghue, Gaetano M De Ferrari, et al.
Journal of the American College of Cardiology
|
January 30, 2016
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial
Sabina A Murphy, Christopher P Cannon, Michael A Blazing, et al.
European Heart Journal
|
June 3, 2026
Safety of low lipoprotein(a) levels: the FOURIER trial
Baris Gencer, Robert P Giugliano, Xinhui Ran, et al.
The New England Journal of Medicine
|
August 17, 2017
Cognitive Function in a Randomized Trial of Evolocumab
Robert P Giugliano, François Mach, Kenton Zavitz, et al.
Circulation
|
February 22, 2019
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, et al.
Lancet (London, England)
|
November 15, 2018
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, et al.
Circulation
|
August 29, 2022
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
Michelle L O'Donoghue, Robert P Giugliano, Stephen D Wiviott, et al.
Journal of the American Heart Association
|
February 9, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Giulia Magnani, Diego Ardissino, KyungAh Im, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 73) with videos related to
Sort By:
Page
of 8
JAMA Cardiology
|
May 1, 2018
Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial
Brian A Bergmark, Jacob A Udell, David A Morrow, et al.
Hepatology (Baltimore, Md.)
|
May 26, 2007
Myxovirus-1 and protein kinase haplotypes and fibrosis in chronic hepatitis C virus
Leland J Yee, Yong-Ming Tang, David E Kleiner, et al.
Journal of the American College of Cardiology
|
February 7, 2024
Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
Daniel J McClintick, Michelle L O'Donoghue, Gaetano M De Ferrari, et al.
Journal of the American College of Cardiology
|
January 30, 2016
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial
Sabina A Murphy, Christopher P Cannon, Michael A Blazing, et al.
European Heart Journal
|
June 3, 2026
Safety of low lipoprotein(a) levels: the FOURIER trial
Baris Gencer, Robert P Giugliano, Xinhui Ran, et al.
The New England Journal of Medicine
|
August 17, 2017
Cognitive Function in a Randomized Trial of Evolocumab
Robert P Giugliano, François Mach, Kenton Zavitz, et al.
Circulation
|
February 22, 2019
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, et al.
Lancet (London, England)
|
November 15, 2018
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, et al.
Circulation
|
August 29, 2022
Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease
Michelle L O'Donoghue, Robert P Giugliano, Stephen D Wiviott, et al.
Journal of the American Heart Association
|
February 9, 2021
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long-Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Giulia Magnani, Diego Ardissino, KyungAh Im, et al.
Page
of 8